Sulfated surfaces in sensitivity: an 'on-off' switch for anaphylaxis?
Related Experiment Video
Updated: Aug 14, 2026

Basophil Activation Test for Investigation of IgE-Mediated Mechanisms in Drug Hypersensitivity
Published on: September 16, 2011
1Department of Radiology, University of California, La Jolla 92093.
Abstract:
Activation of the plasma contact system with the production of bradykinin appears to play a role in X-ray contrast material reactions and in some forms of anaphylaxis. We have noted that the plasmas of contrast material reactors and some asthmatics show an accelerated rate of contact activity when exposed to exogenous contact activators at low temperatures, and we have identified two plasma priming substances (endogenous contact activators; ECA) that contribute to this potential activity. One primer appears to be a sulfated polysaccharide or proteoglycan that resembles heparin and/or heparan sulfate in its properties. Plasmas containing this primer show a cold-promoted activation of factor VII (CPA) as described by Gjonnaess (Thromb. Diathes. Haemorrh. 1972; 28: 169-181) and found particularly in high estrogen states. These plasmas also show spontaneous amidolytic (contact system) activity on cold incubation, and potentiated amidolytic activity when exposed to exogenous sulfated negative surfaces. A consideration of these findings and data in the literature suggest that these surfaces may originate on endothelial linings, may be increased in concentration by immunization and estrogens, and decreased by corticosteroid pretreatment. These considerations merit further study and may be the basis for the observed increase in asthma/allergy symptoms in some females during high estrogen periods.
Related Concept Videos
Allergic Reactions
Desensitization and Tachyphylaxis
Several...
Hypersensitivities
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Modified-Release Drug Delivery Systems: Stimuli-Activated
Drug Toxicity: Allergic Reactions
Allergic Reactions: Anaphylaxis

